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4.1. General overview 
4.1.1 Global burden of cardiovascular diseases   
At the end of the XIXth century infectious diseases, injuries and malnutrition were the most 
common causes of death worldwide. Diseases of cardiovascular system were responsible for less than 10% 
of all deaths. Following the age of epidemiological transition, to the beginning of the 21st century 
cardiovascular diseases have become the most common cause of death worldwide, accounting for about 
30% of all deaths, including approximately 40% in developed industrial countries (1). Coronary Heart 
Disease (CHD) and cerebrovascular diseases became the most common causes of death throughout the 
world, accounting for 12.2 and 9.7 % of total death toll or, respectively, 7.2 and 5.7 million deaths per year. 
Men die more often from cardiovascular diseases (31.5%) than women (26.8%) (2).  
 
4.1.2 Mortality from cardiovascular diseases in Russia 
Deaths due to cardiovascular diseases (CVD) constituted about 55% of all-cause mortality in 2003 
(age-standardized to the world standard population mortality rate of 871 cases per 100.000 inhabitants). 
CHD (ICD-10 codes I20-I25) and cerebrovascular diseases (ICD-10 codes I60-I69) constituted 26.4% and 
20.2% of total mortality (3). The age-standardized mortality rates for CHD and cerebrovascular diseases 
were 414.6 and 316.5 per 100.000.  
 The CVD mortality is high in both genders. The crude rates for men (815.8 per 100.000) are even 
lower than for women (852.4 per 100.000) (4). However, the age-standardized to the European standard 
population rates in men are much higher than in women, respectively, 913.3 and 441.0 per 100.000 (5) due 
to high CVD mortality rate in young and middle age (3). Vaguely defined diagnostic subcategories; 
“Chronic Ischemic Heart Disease” (ICD-10 codes I25.0-25.9) and “Other (than acute myocardial infarction) 
forms of acute or sub-acute ischemia” (ICD-10 codes I24.0-24.9) constitute about 80% of mortality from 
CHD(6). Acute myocardial infarction (AMI) composes, respectively, only 7.7% and 5.9% in the overall 
burden of cardiovascular mortality in the middle aged men and women (Table 1). Whereas the group of 
cardiovascular nosologies with vaguely defined diagnostic criteria such as “Other forms of acute or sub-
acute ischemia” and “Chronic Ischemic Heart Disease” constitute, respectively, 30.6% and 16.2% in men, 
and 22.2% and 16.2% in women of overall CVD mortality. The use of term Coronary Heart Disease in 
medical literature often implies angina pectoris and acute myocardial infarction (nosologies with definite 
clinical signs and symptoms, laboratory and ECG-findings) as its main compound. In the Russian routine 
mortality statistics AMI constitutes only 14% of all fatal CHD-outcomes (Table 1).  
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Table 1 Age-standardized¹ mortality rate from cardiovascular diseases² among young (15-34 years) 
and middle aged (35-69) Russians by gender in 2006, per 100.000 persons 
   
Death diagnoses Men Women 
 15-34 35-69 15-34 35-69 
All cardiovascular diseases (I00-99) 48.6 1054 13.8 368 
     -Coronary Heart Disease (I20-25)     
          -Myocardial infarction (I21-23) 1.33 81.2 0.19 21.7 
          -Other forms of acute and chronic           
ischemia³ (I24) 10.4 322 2.06 81.6 
          -Atherosclerotic heart disease (I25) 1.13 171 0.27 59.7 
     -Cerebrovascular diseases (I60-69) 5.41 261 2.54 125 
¹Age-standardized to the world standard population 
²In brackets included corresponding ICD-10 codes 
³Is often reflected in death certificates as acute coronary insufficiency and acute heart failure 
 
In contrast, of 735 CHD deaths of males aged 35-69 years in Norway in 2008 (7), 472 (64%) were 
classified as AMI and only 168 (34.1%) deaths were attributed to “Chronic Ischemic Heart Disease”. 
Corresponding figures for women were: 187 (100%) CHD deaths, 137 (73.3%) and 46 (24.6%). Myocardial 
infarction composed 35.7% of all CVD deaths in men and 30.0% in women. No deaths were allocated into 
the category “Other acute or sub-acute ischemic heart diseases” in the age-group 35-69 years! 
It is difficult to explain the high proportion of vague CVD diagnoses because about 40-50% of all 
death certificates issued in Russia are based on the results of a postmortem pathological examination 
(autopsy). In the Arkhangelsk region in 2009, 64% of all diagnoses in death certificates were made by 
either hospital pathologist or forensic pathologist. In the city of Arkhangelsk, 92% of all death diagnoses 
were based on autopsy in 2009 (8)!  
 
4.1.3 Comparison of CVD mortality in Russia with other European countries 
The annual absolute number of deaths from CHD and stroke in Russia is comparable with such 
demographic giants as China and India, having the highest absolute number of deaths from these diseases in 
the world. However, the Russian population is about 8-9 times smaller than the Indian or the Chinese ones 
(9).  
Although Siberia or the Asian part, situated to the east from Urals, constitutes about ¾ of Russia’s 
territory, it accounts for only ¼ of the population. According to the census performed in 2002, ethnic 
Russians constituted over 80% of the population (10). These facts call for comparison of Russian mortality 
data with the corresponding figures from Europe. Age-standardized mortality rates in 2003 according to the 
WHO (3) are shown in Table 2.  
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Table 2 Mortality from all causes and cardiovascular diseases in Russia (2003), countries of Central 
and Eastern Europe¹ (Eur-B+C; 2003), countries of Western Europe² (Eur-A; 2002) and Russia-to-
Eur-A ratio by age and gender: SDR per 100.000 population  
 
Age groups and   Males   Females  
causes of death Russia Eur-B+C Eur-A Rus/Eur-A Russia Eur-B+C Eur-A Rus/Eur-A 
0-14         
   All causes 166.4 170.5 55.3 3.0 122.5 131.9 43.3 2.8 
   CVD 1.9 3.3 1.4 1.4 1.5 2.6 1.3 1.2 
15-29          
   All causes 381.4 241.7 82.0 4.7 108.1 79.0 29.3 3.7 
   CVD 26.2 17.6 4.1 6.4 8.4 7.3 2.3 3.7 
30-44         
   All causes 1060.8 700.0 161.6 6.6 293.4 215.6 78.5 3.7 
   CVD 243.8 158.6 26.1 9.3 64.0 45.3 10.4 6.2 
      -CHD      111.0 73.7 11.8 9.4 20.3 14.4 2.4 8.5 
      -Cerebrovascular diseases 34.2 24.6 4.4 7.8 13.7 10.6 3.6 3.8 
45-59         
   All causes 2702.4 1981.7 580.1 4.7 864.8 698.9 293.3 2.9 
   CVD 1112.8 793.1 156.4 7.1 350.8 271.7 50.9 6.9 
      -CHD      623.8 435.3 86.2 7.2 144.0 111.1 17.8 8.1 
      -Cerebrovascular diseases 233.2 168.6 23.7 9.8 113.9 88.4 14.5 7.9 
60-74         
   All causes 6131.6 4996.4 2156.9 2.8 2601.9 2339.0 1069.2 2.4 
   CVD 3661.1 2903.0 744.9 4.9 1728.1 1507.8 335.7 5.1 
      -CHD      1960.9 1582.2 381.3 5.1 791.7 731.4 133.5 5.9 
      -Cerebrovascular diseases 1218.0 833.7 143.3 8.5 712.3 528.9 86.7 8.2 
75+         
   All causes 17258.3 14838.0 9832.0 1.8 12137.2 11421.7 7112.5 1.7 
   CVD 11617.8 10221.2 4356.2 2.7 9510.1 8805.6 3577.9 2.7 
      -CHD      5674.0 4925.6 1708.0 3.3 4136.3 4028.6 1150.0 3.6 
      -Cerebrovascular diseases 4465.8 3004.4 1119.8 4.0 4135.0 2967.6 1026.9 4.0 
¹Eur-B+C comprises Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Estonia, Georgia, Hungary, 
Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Poland, Republic of Moldova, Romania, Russia, Serbia and Montenegro, Slovakia, 
Tajikistan, Turkey, Turkmenistan, Ukraine and Uzbekistan 
²Eur-A comprises Andorra, Austria, Belgium, Croatia, Cyprus, the Czech Republic, Denmark, Germany, Greece, Finland, France, 
Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, the Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, 
Sweden, Switzerland and the United Kingdom 
  
 
Some important conclusions can be drawn from the data in the table: 
 1. The cardiovascular and CHD disease mortality rates in Russian adults are higher in all age-groups, 
except for the youngest age-group (Table 2), than the average rates in the countries of Central and Eastern 
Europe. The gap in CVD mortality rates markedly increases when age- and sex-specific rates in Russia are 
compared to the corresponding figures from the Western Europe (Eur-A). The ratio of the CVD mortality in 
Russia to the average CVD mortality in the Eur-A countries varied from 1.4 to 9.3 in men and from 1.2 to 
6.9 in women, being highest in the middle-aged. The incidence of fatal cardiovascular events among 30-44 
and 45-59 year old Russian men in 2003 was, respectively, 9.3 and 7.1 times higher than the corresponding 
average estimates for the Eur-A countries. If the cardiovascular mortality rate in Russia had been the same 
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as in Western Europe (the age and gender distribution of the Russian population in 2002(11) is applied), the 
total number of cardiovascular deaths in 2003 would have been reduced by app. 1 million! It would spare 
about half a million lives of men and women, with ⅓ of men’s and 10% of women’s lives in the active 
working ages (30-59 years). It leads us to the third important feature of CVD mortality in Russia; 
2. The all-cause and cardiovascular mortality rate in men in all age groups is considerably higher 
than the mortality rate in women in Russia. The difference is largest among the middle-aged and is the most 
obvious for CHD-deaths. The male-to-female CHD mortality rate ratio (MRR) in age-groups 30-44 and 45-
59 years in 2003 was 5.5 and 4.3. Corresponding MRR for CVD in general, was 3.8 and 3.2. The absolute 
difference in mortality between men and women is more evident than the relative one (MRR). If such large 
male-to-female difference in all-cause mortality might be explained by a four times higher mortality from 
external causes (accidents, poisonings, suicides, violence) among men (4), the underlying reasons for 
differences between genders in CVD mortality, and particularly, CHD mortality are less evident.    
 3. Cardiovascular death in Russian men occurs, in average, much earlier than in women. A very 
high CVD mortality in middle-aged men is an important cause of the low life expectancy among Russian 
men, which results to the largest in Europe gap in life expectancy between men and women. The life 
expectancy at birth in 2003 was 58.6 years for men and 71.8 years for women, corresponding figures in 
2008 were 61.8 and 74.2 years(12).  
 
 4.1.4 Historical aspects of mortality from cardiovascular diseases in Russia 
 The Russian mortality crisis at the end of the XXth century 
 After the collapse of the Soviet Union in 1991, Russia has experienced an abrupt reduction in life 
expectancy at birth due to increasing mortality. The increasing number of cardiovascular deaths was its 
main driving force (Figure 1) (13). During just three years, CVD mortality rate has increased by 35% (from 
621 in 1991 to 837.5 deaths per 100.000 in 1994). It was followed by 37.5% increase in total mortality 
(from 1139.3 to 1566.5 deaths per 100.000 during the same period). This dramatic increment was 
characterized as “beyond the peacetime experience of industrialized countries”(14) or “unprecedented in a 
modern industrialized country in peacetime”(15). In Russia it became known as “Yeltsin’s genocide” and 
coincided with the collapse of the Soviet Union and the initiation of a profound societal transformation, 
liberalization of the economy, including the alcohol market, and the abolishment of the state’s monopoly on 








 Since the beginning of the 1990s a wave-shaped pattern persists in CVD and all-cause mortality 
(Figure 1) with no obvious trends for improvement until now. Thus, the highest ever registered 
cardiovascular mortality in Russia (927.5 deaths per 100.000 inhabitants) was observed in 2003. 
 
 Cardiovascular and all-cause mortality in the Soviet Union 
The Russian mortality crisis of the 1990s has attracted worldwide attention. The leading biomedical 
journals have published expert opinions, analyses of national mortality statistics and results of a few 
epidemiological studies. However, the mortality in the period before the collapse of the USSR attracted less 
attention. Therefore, it may give a misleading impression of that Russia has encountered the problem of 
increasing CVD mortality for the first time in 1991 and before the mortality was decreasing.  
 The author could not find a detailed cause-specific mortality statistics for the first half of the XXth 
century. It is possible that it simply does not exist for this period, which can be described as a period of 
demographic disaster or the period of intermittent social catastrophes. Three such demographic crises may 
be clearly defined: 1914-1922, (World War I, followed by the October revolution, Civil War and famine), 
1930-1936, (Stalin’s “collectivization” with arrests and executions of millions of the better-off peasants and 
their families and followed by famine), 1941-1948, (the Great Patriotic War and famine of 1946-47). Only 
the number of direct “excessive” losses of human lives during the period from 1927 to 1947 is 35 millions! 
There is however no agreement about this number. It is likely that the real estimates are even higher(16). 
During these years, deaths from violence, malnutrition and infectious diseases determined the mortality. 
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One may only suggest that deaths from a cardiovascular disease at the first half of the XXth century in 
Russia were not as common as in our days.  
 The first reliable sex-, age- and cause-specific mortality data from the Soviet Union are available 
from 1965. They were openly published first only in the 1980s and were not available to the public before 
the Gorbachev’s “perestroika”. There were substantial reasons for this, since during the period of 
ideological opposition they could be used as a weapon in the Cold War.  
Following the end of the World War II and the famine in 1946-47 the life-expectancy has abruptly 
increased during the following 15 years. Russia entered the second phase of epidemiologic transition, 
characterized by improvements in nutrition and public health, an abrupt decline of mortality from infectious 
diseases, malnutrition and violence, as well as a low mortality of infants and children. The delay time from 
the western European countries constituted about 35-40 years.  
 The health gains were impressive, and the West-East differences in life-expectancy quickly and 
dramatically decreased. In 1964, the highest ever recorded life-expectancy among men (64.9 years) was 
registered; the corresponding one for women was 73.6 years (Figure 2).These estimates were lower than in 
western Europe (for comparison provided sex-specific data for Norway), but they were higher than the 
Russian national estimates in 2008(12;17).  
 




In 1964, the life-expectancy for both sexes was 69.9 years, which was almost identical to the one in 
the U.S. (70.3 years) and close to the one in Norway (73.6 years). These results, although important and 
impressive, were broadly used for propaganda of the Soviet regime’s achievements. However, since 1964 
the life expectancy has either stagnated or fallen in Russia, whereas it has been slowly increasing in 
Western Europe (Figure 2) and the U.S. As one of the main factors behind the reduction in life-expectancy, 
Russian experts blame the state’s alcohol policy. The government urgently lacking money for the expensive 
nuclear arm race and space program, having the monopoly on alcohol production and sales, reduced prices 
at the beginning of 1960s, which stimulated alcohol consumption and filled the budget with “drunk 
money”(18). Since that time sale of alcohol has been an important source of income for the state’s budget. 
Two main groups of causes of death have dominated Russian mortality statistics since 1965 (4): 
cardiovascular diseases and external causes. The crude CVD mortality rate has tripled (Figure 3) in men 
and doubled in women from 1965 to 2008 (4). On the contrary, in the Western European countries, the 
mortality trends have been the opposite. In Norway, the age-standardized cardiovascular mortality rate has 





Notably, the mortality rate from AMI in Russia remained constant at a relatively low level in both 
genders since 1965(6;20). However, the weight of the group with vaguely defined diagnostic criteria “other 
forms of acute or sub-acute ischemia” in CHD mortality has increased constantly (Figure 4). This increment 
particularly accelerated at the beginning of 1990s after the  
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collapse of the Soviet Union and coincided with the abrupt increase in CVD mortality. The mortality from 




4.1.5 The importance of the problem 
The high cardiovascular disease mortality may be characterized as an epidemic in Russia. 
Associated demographic and socio-economic detriment translated this problem from the rank of a common 
public health issue into the category of high priority national security challenges. Cardiovascular diseases 
are the leading cause of premature death and disability in the country, particularly among men of working 
age. Since the beginning of 1990s when cardiovascular and all-cause mortality has abruptly increased and 
the birth rate has fallen dramatically, the population of the Russian Federation is shrinking. In 2006, the 
Russian population might have been reduced by 687.100, but due to positive migration, it only decreased 
by 532.600 individuals (21). From 2002 to 2010 the population of Russia has shrunk by 2.2 million (1.6%) 
despite of annual migration of hundreds of thousands into the country (22).  
 
The scale of the problem was recognized by the Russian government as one of the “most acute” and 
“fundamental” challenges for the development of the state and the civil society. In 2005, president Putin 
addressed the demographic problem in his speech to the nation (23) where he particularly stressed the 
significance of alcohol abuse as an important cause of the high mortality in the country.  
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 High mortality in young and middle aged men causes gender imbalance, which is one of the largest 
in the world. There are 0.872 males to one female (11). The gap becomes evident at the age of 40 years and 
then continuously increases. The number of men aged 60 years or more in the Arkhangelsk region in 2006 
was 63244; the corresponding number of women was 133492. The male-to-female ratio was 0.47 (24). The 
corresponding male-to-female ratio at the same year in Norway was 0.80 (25).  
 The population of Russia is an “aging population” with a low proportion of individuals in the age 
under 15 years, a high proportion of people older than 60, a high median age, a low total fertility rate, 
neonatal mortality rate and a maternal mortality rate (Table 3). Sharing these common features with other 
“old” European populations, the Russian population is marked by high adult mortality rate resulting in low 
life expectancy (26). 
 

















Indicator Russia Norway Year Rus/Nor ratio¹ 
Population proportion under 15 
years (%) 15.0 19.0 2006 - 
Population proportion over 60 
years (%) 17.0 20.0 2006 - 
Total fertility rate (per woman), N 1.3 1.8 2006 0.72 
Population median age, years 37.0 38.0 2006 - 
Adult mortality rate, men² 432.0 86.0 2006 5.02 
Adult mortality rate, women 158.0 53.0 2006 2.98 
CVD mortality rate³ 688.0 181.0 2002 3.8 
Mortality from injuries³ 217.0 35.0 2002 6.2 
Life expectancy at birth (years), 
women 73.0 83.0 2006 - 
Life expectancy at birth (years), 
men 60.0 78.0 2006 - 
Maternal mortality ratio 
(per 100.000 live births) 28.0 7.0 2005 4.0 
Neonatal mortality rate  
(per 1000 live births) 7.0 2.0 2004 3.5 
¹ Ratio of an indicator for Russia to the corresponding one for Norway 
² Probability of dying between 15 to 60 years per 1000 of population 










4.2. Possible explanations for high CVD mortality in Russia 
4.2.1. Established major risk factors for CVD 
A high prevalence of conventional cardiovascular risk factors (smoking, dyslipidemia, arterial 
hypertension, overweight and obesity, diabetes mellitus) in Russia would be the simplest and the expected 
explanation of high CVD mortality rates. WHO’s Multinational Monitoring of Trends and Determinants in 
Cardiovascular Disease (MONICA) Project provided the largest and the reliable source of data on CVD 
mortality and risk factors to test this hypothesis. The study was performed in Moscow and Novosibirsk (a 
large industrial and scientific center in West Siberia with a population of about 1.5 million people). Three 
surveys based on independent probability samples were carried out in Moscow (in 1984-86, 1988-89 and 
1992-95) and two surveys in Novosibirsk (at the beginning and at the end of the 10-year study period in 
1985-86 and 1994-1995). Altogether 5678 men and 5939 women aged 35-64 years participated (27;28). 
The population distribution of current cigarette smoking, systolic blood pressure, total cholesterol and BMI 
were assessed individually and summarized in a risk score. The MONICA study established an effective 
standardized mechanism for registration of CHD and stroke events, which have been monitored during a 
10-year period. The trends in the abovementioned risk factors and CHD mortality were compared within 34 
populations from 20 countries. The study failed to explain high CHD mortality in the Russian cohorts with 
high levels of the “classic” risk factors, assessed neither separately nor jointly as a risk score. Moreover, the 
average population risk score levels were lower in Russians (27), than in some western European 
populations with lower cardiovascular mortality rates (Finland, Sweden, the United Kingdom and some 
other). Notably, the pattern of association in trends for these four risk factors with the trends in coronary 
(27) and stroke event rates (29) in multiple-regression analyses in the four Russian and the Lithuanian 
MONICA populations, was totally different from the other populations in the study. While CHD and stroke 
event rates were increasing in these former Soviet Union countries, a favorable trend in the CVD risk 
factors has been observed. These five populations poorly fit the regression model and therefore were 
excluded from the analyses. A strong negative association between the trends in coronary events and BMI 
was found in men in all four Russian populations. As a plausible explanation for the discrepant results it 
was suggested that the increase in coronary event rates in Russia was driven by other factors, such as 
hazardous alcohol consumption and misattribution of deaths from other causes to CHD-deaths (27).  
Another important finding of the MONICA study was the low diagnostic precision for fatal 
coronary events in the Russian populations. About one fifth of all deaths, certified as deaths due to CHD, 
has not been confirmed by the well organized and standardized between the study populations validation 
procedure (28). This proportion was the highest among all participating populations. A case fatality rate for 
CHD patients of 57% in men and 60% in women reported for both Moscow populations was among the 
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highest of all MONICA populations. It is necessary to mention that the quality of healthcare services in 
Moscow is, in general, remarkably higher than in other Russian territories, since the city concentrates the 
country’s financial, intellectual and technical resources.  
 
The distribution of the major cardiovascular risk factors in Russia was further compared with three 
Scandinavian populations: a Finnish(30), a Swedish(31) and a Norwegian (Tromsø)(32). Findings from 
these studies were generally in line with those reported in the MONICA study (Table 4). The 
cardiovascular risk scores based on the major conventional cardiovascular risk factors in Russian 
populations were either lower or equal to the scores reported for the Nordic populations. Only prevalence of 
smoking was considerably higher among Russian men than among men in the Western populations. It was 
concluded that classical risk factors do not provide a complete explanation for the high mortality in the 
former Soviet Union countries (33). The authors have also suggested that psychosocial, nutritional, socio-















Table 4 Age-adjusted means of cardiovascular risk factors in men and women from the Russian population-based samples and  
the corresponding samples of Western populations. P-values are given for difference between the Russian and Finnish estimates.  
 
1TC-total cholesterol, HDL-C -high-density lipoprotein cholesterol, TG-triglycerides, SBP-systolic blood pressure, DBP-diastolic blood pressure, BMI-body mass index  
 Russian vs. Swedish Russian vs. Finnish Russian vs. Norwegian Russian vs. MONICA 
 Mean(SD) Mean(SD) Mean(SD) Mean(SD) 
p-value 
Mean(SD) Mean(SD) Mean4 Mean4 
MEN Russian Swedish Russian Finnish  Russian Norwegian Russian  MONICA 
TC, mmol/l, mean ± SD1 5.23±0.06 6.29±0.10 5.19±0.93 5.84±1.12 <0.001 5.0±1.2 6.1±1.2 5.3 (-0.021) 5.8 (-0.008) 
HDL-C, mmol/l, mean± SD 1.36±0.02 1.23±0.25 1.38±0.36 1.28±0.33 <0.001 1.3±0.4 1.3±0.4 - - 
TG, mmol/l,  mean ± SD 1.24±0.04 1.66±0.11 1.20±0.72 1.86±1.21 <0.001 1.4±0.9 1.8±1.1 - - 
SBP, mmHg, mean ± SD 134.9±1.24 130.8±1.49 142±23 140±19 ns 133.5±19.0 137.5±17.4 130 (-0.39) 133 (-0.21) 
DBP, mmHg,  mean ± SD 87.6±0.67 83.0±0.96 83±13 83±13 ns 75.7±14.6 79.9±11.8 - - 
BMI, kg/m²,  mean ± SD 26.11±0.20 26.44±0.30 25.2±4.0 27.0±4.0 <0.001 25.3±4.0 25.6±3.3 25.2 (-0.07) 26.6 (0.05) 
Smoking, % 56.3±2.80 20.6±3.41 65 31 <0.001 56.7 37.4 47 36 
TC ≥6.5 mmol/l,% 12.2±1.82 44.4±4.00 9 27 <0.001  - - - 
Diabetes prevalence, % 4.0±1.10 4.9±1.75 - - - - - - - 
Risk Score 6.92 7.12 - - - 33.8±46.43 45.9±71.93 6.8 (-2.15)2 7.1 (-1.08)2 
WOMEN          
TC, mmol/l, mean ± SD1 5.44±0.07 6.16±0.11 5.32±1.14 5.62±1.12 <0.001 5.1±1.2 6.1±1.4 5.6 (-0.000) 5.8 (-0.015) 
HDL-C, mmol/l, mean± SD 1.48±0.02 1.52±0.03 1.44±0.34 1.53±0.33 <0.001 1.4±0.4 1.6±0.4 - - 
TG, mmol/l,  mean ± SD 1.28±0.04 1.36±0.07 1.22±0.73 1.37±1.0 ns 1.3±0.9 1.3±0.9 - - 
SBP, mmHg, mean ± SD 136.2±1.33 126.7±1.62 144±29 132±21 <0.001 128.1±22.4 131.9±22.6 133 (-0.89) 129 (-0.38) 
DBP, mmHg,  mean ± SD 86.5±0.68 78.5±0.87 82±14 78±11 <0.001 73.0±13.3 76.1±12.7 - - 
BMI, kg/m²,  mean ± SD 29.25±0.39 25.77±0.36 28.0±5.8 26.5±5.1 <0.001 26.0±5.7 24.8±4.2 26.5 (-0.26) 26.5 (0.01) 
Daily smoking, % 5.9±1.30 27.6±3.54 11 16 <0.003 21.3 36.3 14 (-0.11) 21 (-0.14) 
TC ≥6.5 mmol/l,% 16.3±2.09 37.5±3.84 15 20 <0.01 - - - - 
Diabetes prevalence, % 6.6±1.40 5.6±1.82 - - - - - - - 
Risk Score 6.02 6.32 - - - 3.9±6.63 9.8±16.93 6.2 (-2.99)2 6.2 (-1.87)2 
2Risk score defined as a linear combination of the following factors: daily smoking, SBP, TC and BMI 
3Risk score presents a 10-year risk of getting the myocardial infarction 
4Mean with the average annual change of the factor during follow-up 





4.2.2 Other CVD risk factors in Russia 
1. Psychosocial factors 
A large case-control study (INTERHEART) performed in 52 countries and based on 11119 
cases of first AMI and 13648 age- and sex-matched controls found that the psychosocial factors were 
associated with the risk of AMI (34). A presence of depression increased the risk by 55% (OR 1.55; 
99% CI: 1.42-1.69), permanent general stress (work, home or both) and stressful life events in the past 
year were associated with an OR of, respectively, 2.17 (1.84-2.55) and 1.48 (1.33-1.64) (35). These 
results were consistent within different regions, ethnic groups and for both genders. 
 
A cross-sectional population-based study in Arkhangelsk (the Arkhangelsk 2000 study) found 
that 32% of men and 70% of women reported depression and/or anxiety and/or sleeping disorders. 
These percentages were higher than the ones found in Northern Norway (36). In the Arkhangelsk 2000 
study these factors have shown a strong positive association with self-reported cardiovascular disease 
(AMI, stroke and AP). A positive association between depression and CVD mortality has also been 
demonstrated in several cohort studies (37-40). Presence of anxiety and distress was found to be 
associated with higher cardiovascular mortality (40;41). Nevertheless direct evidence of the association 
between psychosocial factors and cardiovascular risk in Russia is still limited.  
 
2. Socio-economic factors (education, marital status and income) are important determinants of 
cardiovascular mortality in western populations (42-45). Low educational and single marital status are 
also factors positively associated with risk of cardiovascular death in Russia (46-50). Some studies 
have concluded that this association was of a similar magnitude as in the west (48).  
 
3. Alcohol consumption 
Results from numerous studies on association between alcohol intake and cardiovascular 
mortality in the west are consistent in that the association follows a U- or L-shaped curve. The lowest 
cardiovascular risk (including both CHD and stroke) was found among moderate drinkers (51-56). The 
US Cancer Prevention Study has examined the longitudinal association (9-year follow-up) between 
alcohol intake and risk of cardiovascular death in nearly half a million old- and middle-aged US 
inhabitants (53). The study found that the risk of CVD death in both genders was lower in all drinking 
categories than in abstainers. The CHD mortality started to increase when a daily consumption of 
alcohol in men without pre-existing CVD exceeded 28-42g (2-3 drinks). The corresponding threshold 
in women was 14g per day (one drink).  
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The current guidelines of American Heart Association state that a daily consumption of 28g of 
alcohol in men and 14g in women is not accompanied with excessive cardiovascular risk (57). A meta-
analysis of 28 cohort studies found that the CHD risk was lowest at a daily consumption of 20g alcohol. 
There were evidences of a protective effect at a consumption level up to 72g/day and cardiovascular 
risk exceeded that of in abstainers when daily consumption was ≥89g (54). The study underlined the 
importance of the drinking pattern in assessment of alcohol-related CHD risk.  
The vast majority of studies have used only “average alcohol consumption” per day, week 
month, etc. as a measure of alcohol consumption. However, the number of drinking episodes may be, 
probably, more important than “the average alcohol consumption” in a country with the drinking 
culture found in Russia. A bottle of vodka taken at one occasion may have different health effects than 
the same volume evenly spread during a week (58). Data on cardiovascular risk associated with alcohol 
binge drinking are limited. Also little is known about how this association is affected by the type of 
alcoholic beverage: wine, spirits or beer. Comparison between studies is difficult because authors use 
different criteria to define binge drinking. Two recently published meta-analyses have concluded that 
episodes of irregular heavy drinking may modify favorable effects of moderate drinking on CHD risk 
in such way, that the cardioprotective effect of moderate drinking disappears (59;60).  
Consumption of large amounts of spirits at one drinking session is a pattern of drinking, which 
is widely spread in Russia, particularly among men (61-63). A study from Arkhangelsk found that 
among all non-abstainers, 52% of men and 17% of women were regular binge drinkers, who consumed 
6 Alcohol Units (1AU=14g of pure alcohol) or more at least once a month. Vodka/liquor and beer 
constituted, respectively, 60% and 30% of the total consumption (64). This pattern of alcohol drinking 
may be associated with higher cardiovascular risk via several biologically plausible mechanisms 
(58;65). Recent epidemiological studies from Russia provided evidence that hazardous alcohol 
consumption is associated with higher cardiovascular risk (66-68). This finding was supported by the 
results of earlier published studies based on aggregated data (69-71).  
 
4. Societal transition and cardiovascular and all-cause mortality 
The break-up of the Soviet Union in December 1991 was followed by the unprecedented 40% 
increase in mortality during the next three years. The break-up has initially been followed by small 
increase in CVD mortality in former socialist countries of Central and Eastern Europe. However, this 
was quickly followed by declining mortality (26). The pattern was different in Russia were the rates 
continued to increase until 2005 (Figure 1). The main factors behind these dramatic changes in 
mortality might be grouped into three broad categories: socioeconomic deprivation, psychosocial stress 
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and increased alcohol consumption, which might also partly mediate the effect of the first two factors 
(72). These three groups of factors correlate and have a tendency to clustering. 
Poverty was quickly increasing after the break-up of the Soviet Union and the collapse of the 
Soviet ruble. In 1992 more than 1/3 of the population lived under the official minimum level of 
subsistence. The true estimate is likely to be higher. The level of inflation has reached an astronomical 
number of more than 13.000% from 1992 to 1995 (73). Tens of millions have lost all savings.  
In Soviet Union, many cities have been built up by large industrial (often military) facilities 
where the majority of population was employed (mono-cities). Such cities as Chelyabinsk (1.100.000 
inhabitants), Krasnoyarsk (930.000), Izhevsk (600.000), and Severodvinsk (250.000) are only few 
examples of large mono-cities. Tens of millions have become unemployed due to the collapse of 
industry and economy in the whole country. Cities with a predominantly unemployed adult population 
appeared. During several months unemployment reached threatening levels. Crimes and violence 
skyrocketed. The situation in rural areas was as catastrophic as in the cities. 
The levels of alcohol consumption were increasing in parallel with the alcohol-related mortality. 
From 1990 to 1994 the proportion of all-cause deaths (both genders) with any Blood Alcohol 
Concentration (BAC) revealed by forensic autopsy has increased from 52.3 to 62.7%. The proportion 
of fatal alcohol poisonings among all deaths from external causes has increased from 9.5 to 18.7% (74). 
The increase in annual per capita alcohol consumption (for age 15+) from 16.2 l in 1991 to 18.5 l in 
1994 was followed by increase in all-cause mortality (75).  
To summarize; both poverty, stress, and alcohol were involved simultaneously as factors 
explaining the mortality increase in Russia during the 1990s. It seems difficult to separate the impact of 
one single factor due to the complex interplay between them and the limited data on this issue.  
 
5. Dietary factors 
The two main dietary factors associated with an increased CVD risk are high saturated fat 
intake and low consumption of fresh fruits and vegetables.  
A high consumption of animal fat is associated with an unfavorable lipid status and, primarily, 
high serum total cholesterol (TC) levels, which is a major cardiovascular risk factor (76;77). If dietary 
intake of saturated fats was higher in Russia than in the West, this would mean that the mean serum 
levels of TC, triglycerides and LDL-cholesterol would also be higher. However, the results of 
epidemiological studies show that they were, in fact, lower or equal in Russian men and women (Table 
4). It is also reasonable to suggest that the intake of animal fats was low in Russia where a system of 
distribution, based on food cards was introduced already in mid-80s. Strict quotas of consumption 
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existed for virtually everything; from matches to salt and sugar. At the beginning of 90s, a considerable 
part of the population existed on the border of starvation (73).  
Low dietary intake of antioxidant vitamins (A,C,E) is associated with an increased CVD risk 
(78-84). A strong inverse association between serum levels of vitamin E and A and CHD mortality was 
documented (85). Fresh fruits and vegetables are the main source of vitamins, possessing a protective 
antioxidant activity. The fruits and vegetables also contain many other valuable biologically active 
substances such as bioflavonoids, glutathione, ferulic acid etc. A large number of studies have 
documented beneficial effect of high consumption of fresh fruits and vegetables (86;87). 
There is a lack of epidemiological studies on the prevalence of vitamin deficiency in Russia. In 
a study of 1.000 Finnish and 500 Russian men living in neighbor areas of the Russo-Finnish border, 
plasma ascorbic acid concentrations were compared within the populations. The study showed that 
93% of Russian men had severe vitamin C deficiency and only less than 5% of Finnish men did so (88).  
It is likely that the severe vitamin C deficiency was a marker for low levels of other vitamins and 
antioxidants as well.  
Vitamin deficiency in Russian men is likely worsened by high prevalence of smoking. A study 
comparing the distribution of major risk factors in Russian and Finnish population carried out in the 
same area three years earlier (30) found that the prevalence of smoking in Russian men was much 
higher than in their Finnish counterparts (65 vs. 31%). This proportion is consistent with the findings of 
other comparative studies (Table 4). A combination of low dietary vitamin intake and smoking is 
unfavorable, since both factors increase levels of oxidative stress (81). Hence, exposure to oxidative 














5. AIMS OF THE THESIS 
 
  
• To assess the prevalence of high levels of major cardiovascular risk factors taken 
individually and within the concept of the metabolic syndrome (MetS) in a sample of 
Russian adults 
 
• To study the associations of MetS and its individual components with socio-
demographic and lifestyle characteristics 
 
• To study the associations between the MetS and mortality from cardiovascular diseases 
and all causes in the Arkhangelsk cohort 
 
• To estimate gender-specific effects of the conventional and novel cardiovascular risk 
factors on CVD and all-cause mortality after a 10-year follow-up 
 
• To study associations between alcohol consumption in the hours before death and 
premature cardiovascular mortality in Arkhangelsk 
 
• To assess potential misclassifications of deaths from alcohol poisoning as cardiovascular 
















6. MATERIAL AND METHODS 
6.1 Study design 
Data used in papers I, II and III were collected in population based cohort study. The data on 
exposure were collected in 1999-2000 and the follow-up continued to the 1st of October 2010. Paper IV 
was based on cross-sectional design.  
 
6.2 Background population 
The study was performed in the city of Arkhangelsk, the capital of the Arkhangelsk region in 
Northwest Russia. The population of Arkhangelsk consisted of 154.285 men and 191.359 women in 
2005 (90) and was decreasing. The population which is ethnically homogeneous, consists of 95% of 
Russians and 3% of Ukrainians and Byelorussians and, in general, is representative for Northwestern 
region of Russia (91). The mortality by gender, age and cause of death in the Arkhangelsk region is 
close to the national estimates (92;93).  
 
6.3 Study population (papers I, II, III) 
There was no population register available for medical research in Arkhangelsk in 1999. The 
study participants were recruited from the attendees of one of the largest out-patient clinics in 
Arkhangelsk, the Seamen or “Semashko” clinic. The out-patient clinics provide primary health care to 
the general population by occupational (subjects having a particular occupation) and territorial 
principles (population of a certain district), or both. The out-patient clinics also provide an obligatory 
annual medical examinations of the working and studying population at the age of 18 years or more 
(“dispensarization”).  
From the beginning it was decided to recruit about 4.000 individuals, distributed in age and sex 
groups of a similar size. Participants were consecutively recruited as they came for the annual medical 
examination to the Seamen clinic. They attended the clinic between 8.00 and 12.00 and were asked at 
the registration board to participate in the study. Of those who were invited only 40 subjects (1.1%) 
refused to participate. At the end of the data collection, in 2000 schools and shoe factory were 
contacted and their employees (mainly females) were invited to participate in the study.  
Altogether, 1968 men and 1737 women aged 18 years or more were enrolled. About 90% of 
men and 70% of women were recruited through an annual medical examination. Other participants 
were invited. Workers constituted about 66%, students 12%, pensioners 19% and unemployed 3% of 
the study population.  
 
 22
6.4 Data collection (Paper I-III)  
Individuals who agreed to participate were followed to the study office and registered in the 
journal with individual number. Data were collected by specially trained nurses. At first, 
anthropological measurements were made: height, weight, waist and hip circumference. Height and 
weight were measured in subjects wearing light clothing and without shoes.  
Then each participant went to a separate room were a questionnaire was filled (Appendix I). A 
nurse was present in the room to assist if there were difficulties in understanding the questions.  
At the third stage the participants were guided to another room where blood pressure and heart 
rate were measured. Measurements were made three times with intervals of two minutes, in a sitting 
position, using an electronic automatic device (DINAMAP-R, Criticon, Tampa, Florida).  
Finally the participants were followed to another room where blood samples were drawn. We 
assume that the majority of the participants were fasting, since the annual medical examinations we 
used to recruit the study sample, included screening on diabetes. However, none of the participants was 
directly asked to fast before the medical examination. Venous blood samples were centrifuged within 
15-25 minutes. The serum samples were stored at -20°C and then transported frozen to Norway where 
they were kept at -80°C pending analysis. All laboratory analyses were carried out at the Department of 
Clinical Chemistry of the University Hospital in Northern Norway, using internationally standardized 
procedures.  
Measurement of exposure to alcohol (Papers I, II and III) 
Alcohol intake was described in terms of the drinking frequency and volume of alcohol 
consumption at one drinking episode: 
-The frequency of alcohol consumption was classified into 4 groups: abstainers, ≤1 time a month, 2-4 
times a month, ≥5 times a month. 
-The number of alcohol units (AU) normally consumed on one occasion was categorized as abstainers, 
1-4 AU and ≥5 AU. One AU was equal to 13.8 g of pure alcohol. 
-Data on alcohol consumption by type of drink were collected asking the question: “During the last 
week I drank” (number of AUs) of beer, wine, liquor, in total.  
In paper III several additional estimates of alcohol consumption were used: 
-Frequency of 6 or more AU consumption (6 AU was equivalent to about 250 ml of vodka) at one 
drinking session was presented as never (included abstainers), less than once a month and ≥1 time a 
month 
 23
-the Alcohol Use Disorder Identification Test (AUDIT)(94;95) and the CAGE test(96), respectively, 
consisting of 10 (giving a maximum score of 40) and 4 items (a maximum score of four) were used to 
assess the alcohol intake.  
 Assessment of anxiety and psycho-social distress (Paper III) 
Three indicators were used: presence of depression, sleeping problems and low self-evaluated 
quality of life. The examinees who answered “yes” to the question “Do you have periods of 2 weeks or 
more during which you feel sad, blue or depressed?” were classified as having depression. As having 
sleeping disorders were defined those who answered “yes” to the question “Do you have periods of 2 
weeks or more during which you have problems with sleep?” Quality of life was self-evaluated 
according to a scale from one to ten (Cantril Ladder), where “1” represents the worst quality of life. 
Those subjects who had scored less than 5 were considered as having low quality of life.  
 Laboratory analyses 
Enzymatic colorimetric tests were used to measure total cholesterol (cholesterol esterase, 
cholesterol oxidase) and triglycerides (lipoprotein lipase, glycerokinase, and glycerophosphate oxidase). 
HDL-C was measured by a homogenous enzymatic colorimetric test (PEG cholesterol esterase, and 
PEG peroxidase). If the serum triglycerides (TG) level was less than 4mmol/l, the Friedewald equation 
was used to calculate the LDL-C concentration(97). If the TG concentration was higher than 4mmol/l 
LDL-C was measured directly by an enzymatic colorimetric test. All biochemical analyses of serum 
lipids were performed using a Hitachi 737 analyzer. Serum glucose (SG) was measured by the 
hexokinase method using a Hitachi 917 analyzer. Glycohemoglobin (HBA1c) was determined using 
the Bio-Rad Variant II HPLC system with reagents from Bio-Rad Laboratories (Inc., Hercules, CA 
94547, USA). Apolipoproteins A1and B were assayed by an immunoturbidimetric method with 
polyclonal sheep anti-human apolipoprotein antibodies (Roche). Gamma-glutamyltransferase (GGT) 
was measured by an enzymatic colorimetric test (standardized method, Roche). Aspartate-
aminotransferase (AST) and alanin-aminotransferase (ALT) were measured photometrically by Hitachi 
917 analyzer. Serum C-reactive protein (CRP) was measured by particle-enhanced 
immunoturbidimetric assay in a Roche Modular P analyzer (Roche Diagnostics GmbH, D-68298 
Mannheim). Serum albumin was measured colorimetrically by an automated method using bromcresol 
green as the indicator on Hitachii-917 analyzer. The analytic coefficient of variation was ≤3% for all 
laboratory measurements except TC (5%). 
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Measurement of cardiovascular risk 
As an indicator of cardiovascular risk in Papers I and II we used Metabolic Syndrome (MetS); a 
cluster of four major cardiovascular risk factors such as dyslipidemia, arterial hypertension, 
hyperglycemia and central adiposity (98). Almost all main components constituting the MetS concept, 
are strongly related to atherosclerosis. The presence of the MetS is associated with a predilection for 
atherosclerotic vascular disease (99) and higher cardiovascular mortality and morbidity in western 
countries (100-102).  
There is no uniform internationally accepted definition of the MetS. Six main sets of diagnostic 
criteria have been elaborated by different expert groups. Although they are based on the same 
metabolic components, these definitions interpret weight of individual metabolic abnormalities 
differently. This results in low diagnostic agreement between some definitions. The main difference is 
that some sets of criteria consider central obesity and insulin resistance as the key or obligatory element 
in the MetS’s pathology, whereas the other definitions consider it equal to the other components (103).  
The MetS was defined according to criteria commonly used in scientific literature: by the 
National Cholesterol Education Program Adult Treatment Panel III (NCEP) (104), its modified version 
of the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) (105) and 
International Diabetes Federation (IDF) (106). The prevalence of the MetS was age-standardized 
according to the world standard population and compared with the estimates from western countries.  
 
Follow-up study (Paper II and III) 
 All subjects who participated in the baseline examination 1999-2000 were included in the 
follow-up study. The end-point was death coded according to the ICD-10. Only deaths of the 
participants who were 18 or more years of age at baseline were included in the analyses. The first 
follow-up was performed in 2003-04 and was based on the following sources of data: 
1. The participants’ medical records at the out-patient clinics of Arkhangelsk. Altogether 2851 
(70%) medical records were found at the first follow-up. 
2. The mortality database of the Arkhangelsk Regional Healthcare Department.  
3. Contact by mail of those participants whose medical records were not found (n=1238 or 30.5%).  
They received a letter containing a small questionnaire (Appendix II) about their health status and 
use of medications. Only 229 (18.5%) subjects completed the questionnaire. Because of the low 
response rate contact by mail has not been used since. 
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The vital status was determined for 3099 subjects (76% of the study sample) at the first follow-
up. The same procedure was followed in 2005-06. At this time only approximately 60 % of the initial 
study population was found. The vital status for the participants whose medical records were not found 
was checked through the mortality database of the Arkhangelsk Regional Healthcare Department. This 
is a computerized registry which is based on the official death certificates (Appendix III) issued in the 
Arkhangelsk region. It contains information about the name/surname, date of birth, date and cause of 
death, the address where the deceased was registered and the medical specialist who certified the death. 
The registry was used in 2007 to determine the vital status for all participants during the period from 
1999 to 2007. Since then an annual repeated follow-up based on the registry data was launched. The 
latest data on mortality were available to the 1st October 2010 making the mean duration of follow-up 
10.2 years.  
Validation of cardiovascular deaths 
In 2007 we searched the out-patient records for 142 deaths known to August 2006. The records 
were found for 70 (50%) subjects; among whom 42 (60%) died from a CVD (ICD-10 codes I00-99). 
We validated only 32 deaths from CHD (ICD-10 codes I20-25) and stroke (I60-64). Hospital records 
were found for 7 CHD deaths and 6 stroke deaths and the validation of 19 CHD deaths was only based 
on out-patient records. We assessed the validity of CHD diagnoses based on the criteria proposed by 
the American Heart Association (107). Validation of deaths from stroke was based on the criteria used 
in the MONICA study (108).  
We concluded that the in-hospital diagnostic accuracy for CHD and stroke deaths was high. A 
broad range of diagnostic procedures was applied to make a correct diagnosis. For example, either CT 
or/and MRI scan were performed in all 6 cases of fatal strokes. Accuracy was less for out-of-hospital 
CHD deaths (mainly because of limited data provided in the records), however, we, in principle, agreed 
with all 19 diagnoses.  
Autopsy data on exposure to alcohol before death (paper III) 
When the death certificate was issued by forensic pathologist the Arkhangelsk Regional Centre 
of Forensic Expertise was contacted. Then data on presence of alcohol or surrogates were retrieved 
from the autopsy records. 
Ethics 
The study was approved by the Regional Ethics Committee, Tromsø, Norway. All participants 




6.5 Data collection (Paper IV) 
The mortality database of the Arkhangelsk Regional Healthcare Department was used to 
examine death certificates of all men (n=5065) and women (n=4489) who died in Arkhangelsk 
from 01.01.08 to 31.12.09 (Figure 5). Men (n=1334) and women (n=629) who died from a 
cardiovascular disease (ICD-10 codes I00-99) at the age of 30 to 70 years, were selected. Then 
death certificates issued by a forensic pathologist were selected for 964 men and 390 women.  
The Arkhangelsk Regional Centre of Forensic Expertise where all forensic autopsies in 
Arkhangelsk are performed was contacted and the access to the archive of autopsy reports was 
granted. The data on presence of alcohol at autopsy were retrieved from the autopsy reports for 795 
men and 324 women who died from 01.01.08 to 31.08.2009. A measurement of alcohol 
concentration in body fluids and tissues is a routine part of a forensic examination in case of all 
premature deaths (under 70 years). As a standard, alcohol is measured in blood and urine. In some 
cases it is also detected in specimens of gastric mucosa or the thigh muscle. The alcohol 
concentration is measured by gas chromatography(109) in g/l with a detection limit of 0.0001g/l.  
The ethical approval of the study was obtained from the Ethical Committee of the Northern 
State Medical University in Arkhangelsk.  
 
 
Figure 5. Selection of the study population (paper IV) 
 
5065 men and 4489 women who died from 01.01.08 to 31.12.09 in Arkhangelsk 
 
   
2113 men and 2510 women who died from a CVD (ICD 10 code I00-99) 
  
 
1334 men and 629 women who died from CVD at the age of 30-70 years 
 
 
964 men and 390 women; the death certificate issued by a forensic pathologist 
 
 







6.6 Statistical analyses 
The differences between genders in the studied characteristics were assessed by unpaired t-tests 
and Pearson’s chi-squared tests, respectively, for continuous and categorical variables (Papers I-III). 
Sex-specific cut-offs for waist circumference corresponding to BMIs of ≥25 kg/m² and ≥30 
kg/m² were calculated using a receiver operating characteristic (ROC) analysis. Agreement between the 
MetS definitions was assessed by Cohen’s kappa statistic (paper I). Sex-specific MetS prevalence rates 
(Paper I) and mortality rates (paper IV) were age-standardized to the world standard population.  
Adjusted sex-specific risk estimates for cardiovascular and all-cause death with 95% confidence 
intervals (CI) were assessed using Poisson regression with robust variance estimates (paper II) and Cox 
regression (paper III).  
Odds Ratios (OR) with 95% CI and p-values for probability of being identified with any alcohol 
concentration at autopsy by gender and death diagnosis were calculated using Mantel-Haenszel 
























The prevalence of atherosclerotic vascular disease determinants: MetS and its individual 
components in the Russian population 
We found a large difference in prevalence of MetS between men and women. The prevalence 
rate of MetS defined according to the NCEP criteria was 11.5% (95% CI: 10.1-12.9) in men. This was 
50% lower than in women (19.8%; 95% CI: 18.1-21.5). The MetS prevalence was similar in the 
youngest age-groups (18-29 and 30-39 years). The difference in MetS prevalence increased 
dramatically in the age-group 40-49 years (11.6% in men vs. 19.8% in women) and was almost 2-fold 
in the age-groups 50-59 (18.8% vs. 37.2%) and 60+ years (24.4% vs. 44.8%).  
The age distribution of the individual metabolic abnormalities had similar pattern. Low 
prevalence of the two metabolic components mainly contributed to a lower MetS rates in men than in 
women: central obesity and low serum HDL-C levels. The prevalence of these metabolic abnormalities 
in men was lower in all age-groups compared to women. In the age-groups 50-59 and 60+ years the 
difference was almost 5-fold for central obesity and 1.5-fold for the low HDL-C.  
 
Paper II 
Socio-economic and life-style factors associated with MetS and individual metabolic 
abnormalities, and the association of MetS with cardiovascular and all-cause mortality 
The pattern of alcohol drinking was an important correlate of the MetS in the Arkhangelsk 
adults. Both the frequency of alcohol intake and amount of alcohol consumed at one drinking episode 
were independently associated with MetS and individual metabolic abnormalities. In men, consumption 
of ≥5 AU (≥75g of alcohol) at one drinking episode (binge drinking) was independently related to 50% 
lower prevalence of the MetS, and, respectively, 27%, 21% and 50% lower prevalence of high TG 
levels, low-HDL-C levels and hyperglycemia compared to abstainers. No association with binge 
drinking was found in women in whom, however, a statistically significant inverse association was 
found between the frequency of alcohol intake and MetS. A frequency of alcohol consumption ≥5 
times a month was associated with 60% lower MetS prevalence, a 50% lower prevalence of low HDL-
C levels compared to non-drinkers. The probability of hyperglycemia linearly decreased with the 
frequency of consumption (p=0.03).  
The pattern of alcohol drinking was different in men and women: men consumed alcohol more 
frequently and reported a higher prevalence of binge drinking than women did (47.5% vs. 15.1%). 
About 70% of AUs consumed by men were from liquor (mainly vodka) whereas only 30% was so in 
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women. It was concluded that differences in alcohol consumption between men and women might 
explain the differences in the MetS prevalence. To test the validity of our findings we included several 
biomarkers in the regression analyses: GGT, CRP and AST-to-ALT ratio. All three factors were 
independently associated with MetS in line with previous research.  
No statistically significant association of MetS with all-cause and cardiovascular mortality (I00-
99) was found during a 9-year follow-up. The association was only present in a selected group of 
cerebral strokes (I60-64) and myocardial infarctions (I21-23), and only in men. MetS strongly and 
significantly predicted death from stroke, RR 3.76 (95% CI: 1.35-10.46) and death from either stroke 
or myocardial infarction, RR 2.87 (95% CI: 1.32-6.23) in men. Notably, in a fully adjusted model, men 
with MetS had 27% lower risk of CHD death (I20-25), RR 0.73 (95% CI: 0.30-1.76) than men without 
MetS. Although this finding could be due to chance.  
  
Paper III 
Predictors of cardiovascular and all-cause mortality in Russian adults: a 10-year follow-
up Arkhangelsk study 
The article presents the results of 10-year follow up study of 1966 men and 1738 women, who 
were examined in 1999-00 in Arkhangelsk and followed-up to the October 2010. To our knowledge, 
this study provided the first longitudinal evidence of the association between hazardous alcohol 
consumption and the risk of cardiovascular death in Russian women. A consumption of 6 AU (80g 
alcohol) or more at least monthly was associated with a 5-fold increased risk: RR 5.05 (95% CI: 1.54-
16.7) and binge drinking was associated with a 3-fold risk: RR 3.21 (95% CI: 1.07-9.58) of 
cardiovascular death compared to abstainers. The risk of cardiovascular death increased with the 
frequency of binge drinking (p for trend 0.005). A positive answer on 1 item of the AUDIT and the 
CAGE questionnaires, respectively, increased the risk of cardiovascular death by 1.26 (95% CI: 1.14-
1.40) and 2.45 (95%: 1.44-4.19) times in women. 
In men, the self-reported frequency of alcohol intake of once a month or less and a consumption 
of 1-4 AU (14-56g alcohol) at one drinking episode were associated with a 2-fold increase in risk of 
cardiovascular death. University education and obesity (BMI≥30 kg/m2) were associated with a 40% 
lower risk of all-cause death in men. Low serum albumin was associated with high CVD and all-cause 
mortality in both genders. Higher ApoB/ApoA1-ratio was strongly and directly related to 
cardiovascular mortality in men (RR 7.62 (95% CI: 3.15-18.4) and women (RR 3.12 (95% CI: 1.08-




Premature cardiovascular mortality and alcohol consumption before death in 
Arkhangelsk: an analysis of consecutive series of forensic autopsies  
Firstly, age-specific mortality by the cause of death in Arkhangelsk in 2008-09 was compared 
between men and women. The largest male-to-female MRR was found for cardiovascular mortality 
(MRR of 4.3) and mortality from external causes (MRR 4.6) in the age group 50-59 years. Notably, the 
absolute number of cardiovascular deaths in men was higher in the age 50-59 years (N=525) than in the 
age 60-69 years (N=468).  
Secondly, cardiovascular mortality by cause and age was analyzed in men and women who died 
at the age of 30-70 years. The proportion of deaths certified by a forensic pathologist on the base of 
autopsy increased from 37% in 2006 to 69% in 2008-09. Measurement of alcohol concentration in 
body fluids and tissues is a routine part of the autopsy. We used this favorable opportunity to study 
cardiovascular mortality by postmortem data on alcohol concentration.  
Cardiomyopathies constituted a high proportion of cardiovascular deaths. At the age of 30-59 
years, it constituted 24% and 30% of all cardiovascular deaths, respectively, in men and women. About 
1/3 of men and women, who died from a CVD at the age of 30-59 years, consumed alcohol in the hours 
before dying. Alcohol was more likely to be found at the autopsy of men than that of women who died 
from all cardiovascular causes (OR 1.55; 95% CI: 1.14-2.10), Ischemic Heart Disease (OR 2.04; 95% 
CI: 1.36-3.05) and Chronic Ischemic Heart Disease (OR 2.02; 95% CI: 1.23-3.31). No difference was 
found for deaths from cerebrovascular diseases (I60-69), myocardial infarction (I21-23) and 
cardiomyopathy (I42.0-42.9). 
The study did not support the hypothesis of a substantial misclassification of alcohol poisonings 













 8.1 The validity of the results. Bias and confounding 
 1. Selection bias (papers I-III) 
 No centralized register of general population of Arkhangelsk was available for research, and it 
was not possible to select a random sample of the town’s population. Thus, it was difficult to select a 
representative sample in this situation. The decision to use the obligatory annual medical examination 
at the “Seamen” out-patient clinic to recruit the participants had several limitations. Firstly, the main 
target population for this examination was working seamen and port workers. The vast majority of 
these subjects were men. Arkhangelsk is a large sea-port and has a large fishing and trade fleet; 
therefore seamen and port workers constitute a large proportion of its working male population. 
However, this proportion is smaller than in the study. Some seamen participating in the study (about 
20%) were not residents of the Arkhangelsk region. They lived and had registration in other regions of 
Russia. The latter also had implications for the follow-up.  
 Secondly, the obligatory examination in the “Seamen” out-patient clinic had a limited value for 
the recruitment of female participants. To reach the female population the managements at schools, 
universities and some factories (where employees are mainly women) in Arkhangelsk were contacted 
and their workers were invited to participate in the study. The proportion of the invited women who 
agreed to participate was not assessed. However, presumably, the majority of women who had come to 
the examination offices in the “Seamen” clinic filled in the questionnaire and gave blood for analyses.  
 Thereby, the utilized recruitment methods were not ideal. However, they opened up for a 
recruitment of people with different occupational status, broadly representing general studying and 
working population, and ensured a high participation rate. Age and sex distribution of the study 
population was similar to the general population of Russia (110). A higher proportion of women than 
men in the sample had university education (26.7% vs. 16.3%), which was in line with the national 
estimates for the Russian urban population(111).  
However, unemployed, handicapped, homeless, alcohol abusers and other socially isolated 
individuals were likely to be underrepresented in the study. This problem is common in general to all 
population-based studies, also from Russia; the problem drinkers were also likely to be 
underrepresented in the other large Russian population-based cohorts (the Lipid Research Clinics and 
the Novosibirsk cohorts)(112).  
 On the other hand, samples of working age population recruited about the same time in 
Novosibirsk and Izhevsk, and based on the population registers had response rate of, respectively, 
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61%(113) and 57%(114). The response rate was relatively low despite of a well-elaborated, 
methodologically strong, adequate and expensive recruitment procedure.  
 
2. Selection bias (paper IV) 
The eligible population for analyses of autopsy series was all men (N=1099) and women 
(N=519) who died in Arkhangelsk from a CVD at the age of 30-70 years from 01.01.2008 to 
31.08.2009. Only forensic pathologists routinely measure alcohol concentration. Therefore, we 
included into analyses only 1119 (69.2%) cases where death was certified by a forensic pathologist.  
The high proportion of individuals included in the study from the target population limits the 
potential for selection bias. However, “average” individuals who were more likely to die from a CVD 
in a hospital and, therefore, to be autopsied by a hospital pathologist, might be slightly 
underrepresented in the study. On the contrary, homeless, alcoholics, drug abusers more often die 
outside a hospital and are more likely to be autopsied by a forensic pathologist. Thus, the association 
between premature cardiovascular mortality in Arkhangelsk and alcohol could be slightly 
overestimated.  
 
3. Information bias 
Information bias occurs with the misclassification of exposure either due to incorrect 
information provided by the study subjects, or due to errors in the measurements (115).  
 Measurement bias 
 To minimize the probability of this type of bias, physical examination was performed by the 
experienced and specially trained nurses according to the standard procedure in the same office and 
using the same facility. To avoid interobserver variability, each nurse was responsible for a definite 
part of the examination and followed the protocol strictly.  
 All laboratory analyses were performed in the laboratory of the University Hospital of Northern 
Norway using internationally standardized methods. The laboratory routinely participates in external 
and internal formal quality assurance exercises.  
 Measurement of alcohol concentration (paper IV) was performed according to the national 
standardized methods (116). The results of these measurements should be reliable, because forensic 
autopsy protocols are also used in legal practice.  
 Subject and social desirability bias 
This type of bias occurs when the study subjects either consciously or unconsciously provide 
incorrect information. Analyses in the papers II and III were largely based on self-reported data on 
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pattern of alcohol consumption and smoking. Subjects tend to underreport the level of exposure to 
these socially unacceptable factors(117;118), leading to social desirability bias, which is a subtype of 
the subject bias. An earlier article based on the data collected in 2000 in Arkhangelsk concluded that 
alcohol consumption was substantially underreported in the sample (62).  
The use of obligatory medical examination organized by employer might affect the validity of 
answers. The majority of male participants were seamen with a relatively high salary. These people 
were recruited through the obligatory medical examination organized by their employer. It is possible 
that some of them distrusted our reassurances that the collected data will be unavailable to the 
employer. They might have underreported alcohol consumption to avoid a possible conflict with the 
employer, thus, some hazardous drinkers could be falsely classified as light or moderate drinkers. This 
suggestion is supported by the data; a higher proportion of men than women (14.3% vs. 6.3%) had 
positive result on alcohol at autopsy. It may also explain higher risk of cardiovascular death in 
moderate drinkers (but not in hazardous drinkers) in men. Our finding that the association of frequent 
and binge drinking with cardiovascular mortality was found only in women allowed us to conclude that 
women were more honest than men reporting their drinking habits. 
  
8.1.2 Confounding 
 Confounding is the confusion of two supposedly causal variables, so that part of all of the 
purported effect of one variable is actually due to the other(119). The analyses were stratified by 
gender and the multivariate regression was used to control for possible confounding in papers II and III. 
In paper III we controlled the studied associations for gender (using stratified analyses), age, socio-
economic status (education), life-style factors (alcohol consumption, smoking, physical activity), major 
cardiovascular risk factors (blood pressure, lipid status and BMI) and the history of cardiovascular 
disease (myocardial infarction or stroke). However, as some of the covariates included into the 
regression models were based on self-reported data, we can not exclude residual confounding due to 
imprecise measurement of exposure to these factors (mainly due to underreport).  
Stratification by age, gender and cardiovascular diagnosis was used to present data on 
postmortem alcohol concentration in paper IV.  
 
8.2 Follow-up 
The Arkhangelsk study was initially planned as a cross-sectional study and the reliable follow-
up mechanism was not initially built-in the data collection. From the beginning it was decided to recruit 
similarly sized age and sex groups(32). The sample size of 3705 adults aged 18 years or more was 
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relatively small for a cohort study of mortality. The cohort was also relatively young. Only 638 
(32.5%) men and 626 (36%) women were older than 50 years at baseline. It resulted in a relatively 
small number of deaths and, hence, loss of statistical power. Regular contacts with the participants 
were not established from the beginning. The first attempt to initiate follow-up was undertaken in 2003 
but it was already difficult to establish direct contact with the participants at that time. An attempt to 
contact 1238 subjects by mail in 2003-04 resulted in a response rate of 18.5% and this method was 
abandoned as impractical.  
The possibility to use a telephone book was considered as we had participants’ home address. 
However, it was not possible due to several reasons, including legal restrictions.  
The effectiveness of the originally chosen primary source of mortality data (out-patient clinical 
records) has rapidly decreased. The records were found for 70% of the participants in 2004, whereas 
this proportion was only 50% in 2006. 
Thus, the only available effective source of mortality data was the database of the Arkhangelsk 
Regional Healthcare Department. However, it had several limitations. Firstly, the database covers only 
the Arkhangelsk Region, and those participants who moved from the region during a 10-year follow-up 
period and died “outside”, could not be traced. Secondly, this source of data did not provide us the 
information necessary for censoring people lost to follow-up, which led to underestimation of mortality. 
 To get access to the personal-sensitive data on migration, we have tried to get access to the 
population registries of the Arkhangelsk regional police department and the Arkhangelsk regional 
office of the Pension Fund of the Russian Federation. Official letters have been sent to the heads of 
these two institutions. Both denied access to their registry explaining the denial by the legal restrictions 
in the national body of lows for delivering access to the personal data.  
However, the effect of migration on mortality was, likely, relatively small. It was calculated that 
if the rate of out-migration from the cohort has been the same as from the Arkhangelsk region (120) the 
loss to follow-up would be about 17.5% during the 10-year observation period. The probability of 
migration was higher in young subjects (under 30-40 years), i.e. in the age groups with the lowest 
mortality. 
The expected number of deaths for male and female participants during a 10-year follow-up has 
been calculated. These calculations were based on the official data on cause-specific mortality by sex 
and age in the Arkhangelsk region (92;121). If the all-cause mortality rate in the cohort had been the 
same as in the Arkhangelsk region, we would expect about 366 male and 108 female deaths during a 
10-year follow-up. The ratio of actual/expected number of deaths was 0.4 (147/366) for men and 0.88 
(95/108) for women. To summarize, the difference between the actual and expected mortality is likely 
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explained by three groups of factors: 1. selection of healthier individuals at baseline (healthy worker 
effect); 2. loss to follow-up due to migration and 3. the baseline inclusion of the subjects who had a 
permanent residence in a territory, other than the Arkhangelsk region. The latter was more likely 
among men and might contribute to the explanation of the higher difference between the actual and 
expected number of deaths among them.  
However, these limitations are not unique for the Arkhangelsk study. The latest published large 
cohort study of associations between alcohol intake and mortality in men of Novosibirsk likely had 
somewhat similar limitations (68). The study reported that 91% of the participants were married. But 
this proportion was higher than the proportion, which could be expected if the Russian national 
estimates (122) were applied to the age and sex composition of the study population (70%). The same 
authors reported that the unmarried men had higher mortality from all-cause and cardiovascular 
diseases than married ones (48). This study used, in principle, the same source of data on mortality as 
we did. The used database of the civil registration office (ZAGS) is also based on the information from 
the official death certificates and these data were likely also restricted to the Novosibirsk region. We 
also calculated the number of all-cause deaths expected in this cohort during the median 9.5-year 
follow-up (from 1989 to 1998). The mean of the national age-specific mortality rates for men in 1990 
and 1995 were used(93). The ratio of actual to expected mortality was 0.81 (836/1028), which was 
lower than that for women in our study (0.88). However, the study from Novosibirsk is a valuable and 
reliable one, despite of the aforementioned limitations, which are rather common to all few population-
based cohort studies from Russia.  
 
8.3 Discussion of the main results  
According to the modern concept of Ischemic Heart Disease etiology and pathology widely 
accepted in clinical medicine, the most common cause of IHD is systemic atherosclerosis resulting in 
the atherosclerotic lesions in coronary arteries. The main driving mechanism in IHD’s pathophysiology 
is an imbalance between blood supply and demand in the myocardium. The logical sequence of a 
natural course of an advanced IHD is myocardial infarction (necrosis of the myocardium) (123). 
The main life-style risk factors associated with the severity of atherosclerosis are high-fat and 
energy-rich diet, smoking and sedentary lifestyle. The effect of these factors is mediated by the 
dyslipidemia (high plasma LDL-C and triglycerides and low plasma HDL-C), obesity, diabetes mellitus 
(mainly type 2 diabetes that occurs due to insulin resistance in older ages) and hypertension. All 
aforementioned factors strongly correlate with each other and constitute the concept of the metabolic 
syndrome.  
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Dyslipidemia, which is often seen together with obesity and insulin resistance, results in 
subintimal collection of fat and occurrence of atherosclerotic plaques, which gradually grow and 
narrow the lumen of coronary arteries. If the diameter is reduced by more than 80%, myocardial 
ischemia at rest occurs. However, the cap of a plaque may rupture at any stage of plaque maturation, 
which is followed by occurrence of thrombus, which blocks coronary blood flow and causes 
myocardial ischemia. The ischemia, in turn, causes biochemical, electrical and mechanical dysfunction 
of the myocardium, thereby reducing myocardial pump function. An ischemia that lasts more than 20 
min (for total occlusion of the artery in the absence of collaterals) causes irreversible damage 
(myocardial necrosis). Electrical instability that often occurs in the ischemic area of the heart may 
cause different types of ventricular arrhythmias (from solitary extrasystole to ventricular fibrillation). 
An individual dies from either extensive myocardial necrosis (infarction) resulting in a dramatic 
reduction of the ejection fraction, or from disturbances of the heart rhythm caused by acute ischemia. 
This clear and logically coherent mechanism is currently widely accepted among the clinicians and 
underlies the majority of IHD deaths (123).  
According to the current understanding, systemic atherosclerosis is also the main cause of 
ischemic stroke. This type accounts for approximately 85-90% of all stroke types. The pathophysiology 
of IHD is, in principle, similar to the one of the ischemic stroke(124). 
 
IHD is the leading single cause of cardiovascular and all-cause death in Russia (3). Deaths from 
IHD (I20-25) constituted 59.1% of all CVD deaths in Arkhangelsk in 2009, whereas AMI (I21-22) 
made up only 10% of all IHD deaths and 5.5% of all CVD deaths (92). A similarly low proportion of 
AMI has also been reported in earlier studies from other regions of Russia (6;66). The validity of 
estimates for the low AMI rates, reported in the official mortality statistics in Arkhangelsk region, was 
confirmed in Paper IV. The unusually high proportion of autopsy-verified diagnoses (97%) gives 
credibility to this assessment. AMI constituted only 11% (men) and 20% (women) of deaths from IHD 
at age 30-70 in 2008-09. By contrast, in Norway in 2008; 472 (64%) male and 137 (73.3%) female 
deaths from IHD at age 35-69 were classified as AMI (125).  
The results of the autopsy study led us to conclude that at autopsy there was no evidence of 
clots in a coronary artery, ruptured plaques, or areas of myocardial necrosis in the majority of deaths 
classified as an IHD (126). The immediate cause of about 90% of IHD deaths other than AMI in men 
and 80% in women was defined as acute heart failure. However, its pathophysiological mechanism was 
likely different than that one would expect to find for a typical IHD death (acute thrombus or area of 
myocardial necrosis). In the majority of these cases, the underlying cause of death was defined as 
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chronic ischemic heart disease (ICD-10 I25). Thus the pathologists found atherosclerotic lesions, 
which are typically seen in an aging heart (stable atherosclerotic plaques and, possibly, scarring after 
myocardial infarction), and accordingly defined the acute heart failure to be due to chronic IHD (I25).  
The IHD mortality in Arkhangelsk (and, likely, generally in Russia) could be divided in two 
groups: 1) caused by atherosclerotic heart disease (AMIs); and 2) caused by other factors (likely with 
hazardous alcohol consumption as a major contributor, possibly by aggravating the existing stable 
atherosclerotic lesions). As indicated, the relative weight of the first group is small. The mortality from 
AMI (I21-22) in Russia is comparable to or somewhat lower than that in Western Europe. The age-
standardized for the European standard population mortality rate from AMI (for both genders) in the 
Arkhangelsk region in 2009 was 35.82 per 100.000 (92); by comparison, in Norway (Figure 5) it was 
42.22 per 100.000(127).  
 
Figure 6 
Mortality  from AMI, IHD and all CVDs in Norway and 
Arkhangelsk region in 2009 per 100.000, age-















The mortality in the Arkhangelsk region is similar to the national estimates (93). Hence, the 
large difference in IHD mortality between Western Europe and Russia (Table 2) is likely due to the 
IHD deaths assigned to the second group (caused by nonatherosclerotic factors).  
The low mortality from AMI in Russia is in agreement with the low prevalence of abnormally 
high levels of conventional cardiovascular risk factors associated with systemic atherosclerosis such as 
dyslipidemia, diabetes and obesity (Table 4). The prevalence of these factors was either comparable to 
or lower than in Western populations. The only exception was the prevalence of smoking among 
Russian men, which was about 1.5-fold higher than among their Western counterparts. The particular 
feature of all studies (Table 4) is the considerably more favorable lipid profile in Russian men than for 
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men in Western populations. Although a similar difference was also found for Russian women, its 
magnitude was remarkably smaller than for men. This could also contribute to the explanation of the 2-
fold higher proportion of AMIs within the group of IHD deaths in women than in men.  
To test our hypothesis on this dichotomy of IHD mortality we assessed the atherosclerotic risk 
in the Arkhangelsk study. As a measure of atherosclerotic risk, we used the prevalence of metabolic 
syndrome (98), a cluster of atherogenic cardiovascular risk factors with obesity (particularly abdominal 
obesity) as the core element (106). Atherosclerosis is the primary pathological consequence of MetS 
(128).  
It was found that the age-standardized MetS prevalence rates were either lower (in men) or 
comparable (in women) to rates reported for Western Europe and North America (Paper I). These 
results suggested that MetS (and systemic atherosclerosis) is unlikely to be a major contributor to the 
high CVD mortality in Russian men. The pattern of alcohol consumption was strongly and inversely 
associated with MetS (Paper II). Both high frequency of alcohol drinking and large amount of alcohol 
consumed at one drinking episode were strongly and inversely associated with MetS. The effect of 
alcohol consumption on the metabolic risk reduction was mediated by the improvements in lipid profile 
and insulin sensitivity. It was suggested (Paper II) that the different pattern of alcohol consumption in 
men and women might explain the discrepancy in MetS rates between genders.  
The results of longitudinal analyses were somewhat unexpected and contradictory. No 
statistically significant association of MetS with CHD (I20-25) and cardiovascular (I00-99) mortality 
was found during a 9-year follow-up. Moreover, in the fully adjusted sex-specific regression analyses 
men with MetS unexpectedly had a 27% lower 10-year risk of CHD-death, whereas the corresponding 
risk was 45% higher in women with MetS. Although these results were not statistically significant 
(likely due to low statistical power), this difference is important. Interestingly, MetS appeared to be a 
strong predictor of death in men in the selected group of cerebral strokes and myocardial infarctions, 
supporting the hypothesis of duality of CVD mortality.  
The major cardiovascular risk factors: smoking, high serum TC and TG levels, high BMI were 
not predictive for the risk of cardiovascular death neither in men nor in women after 10-year follow-up 
(Paper III). On the contrary, hazardous alcohol consumption (binge drinking and higher CAGE and 
AUDIT scores) were strongly associated with the risk of CVD death in women. No corresponding 
statistically significant association was revealed in men. However, it is likely that the association with 
hazardous drinking in men was even stronger than in women. Substantial underreporting of alcohol 
consumption by men (62) is likely the reason this was not observed. This hypothesis is supported by 
the following data: (i) men who reported light and moderate alcohol consumption had a 2-fold risk of 
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CVD death compared with abstainers; (ii) higher proportion of men than women (14.3% vs. 6.3%) 
were alcohol-positive at forensic autopsy; (iii) during a 10-year follow-up 7 deaths due to alcohol 
poisoning were registered in the cohort (all in men), representing 1/3 (7/21) of all external-cause deaths 
among men (Paper III); and (iv), alcohol was 55% more likely to be found at forensic autopsy in men 
than in women who died from a CVD (Paper IV).  
The data have shown that alcohol consumption is a factor which is associated with a large 
proportion of CVD deaths in Arkhangelsk. About 30% of men and 22% of women who died from a 
CVD at the age of 30-70 in 2008-09 consumed alcohol in the hours before death according to forensic 
autopsy reports (Paper IV). About 85% of all alcohol-positive deaths in both genders were allocated 
within the two “narrow” diagnostic groups: chronic ischemic heart disease (ICD-10 codes I25.0-I25.9) 
and cardiomyopathies (I42-I42.9). Interestingly, the relative weight of the group cardiomyopathies was 
twice as high in women (44%) than in men (22%), whereas the chronic ischemic heart disease 
accounted for 39% and 63% of the alcohol-positive deaths, respectively. Only 5% (men) and 7% 
(women) of alcohol-positive CVD deaths were allocated within the diagnostic groups: myocardial 
infarction (I21-22) and cerebrovascular diseases (I60-69).  
 
 Public health implications 
The currently prevailing concept of CVD risk reduction is based on the elimination or 
attenuation of effects of the atherosclerotic risk factors. The CVD risk factors recognized by the current 
NCEP ATP III (104) are: hypertension, low HDL-C, diabetes, family history of premature CHD, age, 
obesity, smoking, physical inactivity, atherogenic diet and some emerging risk factors. Alcohol 
consumption is not included into this concept as a risk factor. It is often viewed as a factor reducing 
CVD risk mainly via improvement of the lipid profile and insulin sensitivity, and, thereby, retarding the 
development of atherosclerosis (light-to-moderate drinking). It is probably true in the Western 
populations where light and moderate drinking habits prevail.  
However, the cardiovascular disease risk profile in Russia may be appreciably different to that 
in the US and Western Europe due to high burden of alcohol-related non-atherosclerotic cardiac 
pathologies. The pattern of hazardous alcohol intake (a consumption of large amounts of spirits at one 
drinking episode), which is highly prevalent in Russian men, may dramatically modify the protective 
effect of light-to-moderate alcohol consumption. Therefore, the scope of primary prevention needs to 
extend beyond the standard “Western” approach with its primary focus on diet, smoking and physical 
activity. It is likely that reduction of hazardous drinking through taxation, legislation and effective 
treatment programs will be followed by the substantial reduction of CVD mortality, primarily among 
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men. A large experience accumulated in the Scandinavian countries within the field of alcohol policy 
should be utilized. Cardiovascular risk screening in primary care also needs to consider hazardous 
drinking.  
Implications for further research 
There is an urgent need to conduct a large study (10.000-15.000 individuals) based on a 
representative sample of the Russian adult population aged 35-70 to assess the proportion of CVD 
mortality attributable to hazardous alcohol consumption and to clarify the aetiology of CVD deaths. It 
is desirable to recruit the participants in two or three centers to enhance generalizability of the results. 
Particular attention should be paid to the validity of data on exposure to alcohol. It would be practical 
to combine self-reported data together with biomarkers of recent alcohol consumption, such as: 
carbohydrate-deficient transferrin (CDT), ethyl glucuronide (EtG), EtS, PEth (129), and markers of 
liver inflammation including GGT and Cytokeratin-18 (CK 18) (130). The outcome variable (heart 
disease) should be carefully measured either at baseline (using echocardiography, Holter monitoring 
and/or biomarkers of heart failure, such as beta-natriuretic peptide (131) and high-sensitivity troponin) 
This study should include follow-up based on effective procedure of death registration and validation. 
To avoid severe methodological deviations at the stages of sample selection and collection of data it 
would be desirable to utilize the experience of implementation of the few population-based studies 
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         Appendix II 
Северный Государственный Медицинский Университет 




Уважаемый (-ая),  Фамилия  Имя  Отчество 
 
В 1999-2000 гг. Вы проходили медицинское обследование в рамках совместного 
российско-норвежского проекта "Здоровье человека 2000" на базе поликлиники 
СЦБКБ им.Семашко. Целью проводимого обследования было установление 
вероятности возникновения различных заболеваний. 
 
Группа лиц, у которых был выявлен повышенный риск заболеваний, была 
проинформирована об этом по телефону или письмом в течение первого года после 
обследования. Если Вы не получали такое письмо, то это значит, что результаты 
Ваших анализов на момент обследования  не указывали на повышенный риск  
возникновения заболеваний. 
 
Сейчас, по истечении 4 лет с момента обследования, мы посылаем письмо всем его 
участникам и просим ответить на несколько вопросов о состоянии здоровья и 
приеме лекарств. Эта информация необходима для комплексной оценки состояния 
здоровья и лекарственного обеспечения. 
 
Все сведения, полученные в результате этого обследования, конфиденциальны, а 
медицинский персонал, принимающий участие в разработке и анализе этих 
сведений предупрежден о сохранении врачебной тайны. 
 
В письме Вы найдете вложенный конверт с обратным адресом и оплаченной 
почтовой маркой. Мы просим заполнить небольшую анкету на обратной стороне 
этого листа и отправить ее нам в этом конверте. 
Если Вам в 1999-2004гг. не был поставлен диагноз заболеваний сердца, инсульта, 
сахарного диабета, рака, серьёзной травмы, требующей лечения, то Вам не нужно 
заполнять анкету, отметьте, пожалуйста, здесь  , и пошлите незаполненную анкету 
нам обратно. 
 
Заранее благодарим за сотрудничество, 
 
Северный Государственный Медицинский Университет 
Университет в г. Трумсё, Норвегия 
 
P.S.Если адресат письма переехал, то мы просим Вас отправить письмо нам 
обратно с пометкой: Адресат письма переехал   и, если вы знаете, то укажите, 
пожалуйста, адрес и телефон переехавшего 
............................................................................................................................................... 




1. Отметьте, пожалуйста, если Вам в 1999-2004 гг. был поставлен диагноз: 
 
  когда 
 Да Месяц год 
Инфаркт миокарда           
Стенокардия            
Инсульт (кровоизлияние в мозг)           
Аритмия           
Сахарный диабет           
Рак           






2.Принимаете ли Вы следующие лекарства: 
 
 Нет Иногда Каждый 
день 
Лекарства от повышенногодавления       
Сердечные лекарства                                     
Инсулин                                                           
Таблетки от сахарного диабета                     
 
Для того,чтобы оценить, насколько современные  лекарства Вы 
получаете,напишите,пожалуйста, названия сердечных лекарств или лекарств  от 
давления, которые Вы принимаете (если Вы не помните названия лекарств, то на 















The Northern State Medical University   Number of participant 




Dear, name of the participant 
 
In 1999-2000 you have participated in a medical study in frames of the Russian-
Norwegian project “Human health in year 2000” at the Semashko polyclinic. The aim of 
the study was to assess the risk of getting different diseases. 
 
The group of participants that had high risk of diseases was contacted by telephone or 
letter during the first year after the study. If you have not received such letter, it means 
that the results of your analyses at the moment of the study did not reveal high risk of 
diseases. 
 
Now, 4 years after the study, we are sending letter to all the participants and ask them to 
answer several questions about health status and use of medicines. This information is 
needed for complete evaluation of health status and availability of medicines.  
 
All the information obtained during this study is confidential, and the medical personnel 
taking part in processing and analysis of this information, is bound to preserve 
professional secrecy.  
 
 
In this letter you will find an envelope with return address and paid postal fee. We ask 
you to fill in a questionnaire on the back of this page and to send the answer to us in the 
return envelope. 
 
If you in 1999-2000 did not get diagnosis of heart diseases, stroke, diabetes mellitus, 
cancer or trauma that requires treatment, than you don’t need to fill the questionnaire. 
Please note here   and send the questionnaire back to us.  
 
 
Thank you in advance for your cooperation,  
 
The Northern State Medical University 
University of Tromsø, Norway 
 
P.S. If the addressee of this letter has moved, please send this letter back to us with a 
note: addressee has moved   and, if you know, please write the new address or telephone 
number of the recipient……………………………………………………………………. 
 
If your address has changed, please write your new address 
 
……………………………………………………………………………………………… 
1. Please, note if you in 1999-2004 got the diagnosis of: 
 
 Yes When 
  Month Year 
Myocardial infarction           
Angina pectoris           
Stroke           
Arrhythmia           
Diabetes mellitus           
Cancer           






2. Du you take the following medicines. 
 
 No Sometimes Every day 
Medicines against high blood pressure       
Medicines against heart diseases       
Insulin       
Tablets against diabetes mellitus       
 
To evaluate if you get the up-to-date treatment, please write the names of medicines that 
you are taking against heart diseases or high blood pressure (if you don’t remember the 

















         Appendix III 






Date of issue ”…” …………….. 20.. 
(final, preliminary, issued instead of preliminary, issued instead of final (underline) 
Serial number     ”…” …………….. 20.. 
 
1. Surname, Name, Patronymic of the deceased 
2. Sex: male 1; female 2 
3. Date of birth: date, month, year 
4. Date of death: date, month, year, time 
5. Registration address of the deceased: republic, region, oblast…………………… 
District…………………… Town…………………. Community………………….. 
Street……………………… House……………….. Apartment…………………... 
6. Area: urban 1, rural 2 
7. Place of death: republic, region, oblast…………………… 
District…………………… Town…………………. Community………………….. 
Street……………………… House……………….. Apartment…………………... 
8. Area: urban 1, rural 2 
9. The death has occurred: at the place of accident 1, in the ambulance car 2, in the 
hospital 3, at home 4, at another place 5  
10. For infants who died at the age of 168 hours to 1 month: 
11. For infants who died at the age 168 hours to 1 year 
12. Family status: married 1, unmarried 2, unknown 3 
13. Education; professional: high 1, incomplete high 2, secondary school 3, primary 
school 4; general:  secondary school (complete) 5, primary school 6, basic 7, do not have 
basic education 8, unknown 9. 
14. Working status: has been working in  economy: highly qualified managers and 
specialists 1, other specialists 2, qualified workers 3, non qualified workers 4, military 
personnel 5, has not been working in economy: pensioners 6, students 7, worked at home 
8, unemployed 9, other 10 
15. Death has occurred: due to a disease 1, accident: not associated with an industrial 
production 2, associated with an industrial production 3, murder 4, suicide 5; during: 
military operations 6, terrorist attack 7, type of death was not established 8 
16. In case of death due to accident, murder, suicide, death during military actions and 
terrorist attacks, when type of death has not been established-point the date of trauma 
(intoxication) day……, month………, year…………, time……….., as well as the place 
and the circumstances……………………………………………………………………. 
…………………………………………………………………………………………… 
17. Causes of death were defined by: the medical doctor who has only confirmed the 
death 1, treating doctor 2, feldsher 3, pathologist 4, forensic expert 5. 
18. I, doctor (feldsher, midwife) surname, name, patronymic…………………………... 
working position………………………………………………………………………… 
confirm that based on: examination of the body 1, medical documents 2, observations 
proceeding to death 3, autopsy 4, I have defined the following sequence of the 
pathological process (conditions) which caused the death. 
19. Causes of death: 
 Approximate period of 
time from the 




I. a) The disease or condition which was an immediate cause of 
death 
 ⁯⁯⁯   ⁯ 
⁯b) The pathological condition which was the cause of the 
aforementioned disease (condition) 
 ⁯⁯⁯   ⁯ 
c) The underlying cause of death   ⁯⁯⁯   ⁯ 
d) external cause in cases of trauma or intoxication  ⁯⁯⁯   ⁯ 
   
II. Other important conditions, contributing to death, which, 
however, are not associated with the cause of death, including: 
alcohol consumption, use of narcotics, use of psychotropic and 
other toxic substances, their concentration in the blood, and also 
surgeries (type and date of the surgery)  
 ⁯⁯⁯   ⁯ 
 
20. In case of death due to road accident: 
21. In case of death of the pregnant (irrespectively the term and the localization) 
22. Surname, name, patronymic of the doctor (feldsher, midwife) who has filled-in the 
medical death certificate…………………………………………Signature……………. 
 
 
Chief of the medical organization, 





23. The death certificate was checked by the medical doctor who is responsible for the 
correctness of filling-in the medical certificates. 
 
Date, moth, year                          Signature……………… Surname, name, patronymic 
 
ISBN xxx-xx-xxxx-xxx-x 
 
 
 
